The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease: The diagnosis and management
Open accessAbstract
Non-alcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease that occurs across all age groups and is recognized to occur in 14%-30% of the general population, representing a serious and growing clinical problem due to the growing prevalence of obesity and overweight. Histologically, it resembles alcoholic liver injury but occurs in patients who deny significant alcohol consumption. NAFLD encompasses a spectrum of conditions, ranging from benign hepatocellular steatosis to inflammatory nonalcoholic steatohepatitis, fibrosis, and cirrhosis. The majority of hepatocellular lipids are stored as triglycerides, but other lipid metabolites, such as free fatty acids, cholesterol, and phospholipids, may also be present and play a role in disease progression. NAFLD is associated with obesity and insulin resistance and is considered the hepatic manifestation of the metabolic syndrome, a combination of medical conditions including type 2 diabetes mellitus, hypertension, hyperlipidemia, and visceral adiposity. Confirmation of the diagnosis of NAFLD can usually be achieved by imaging studies; however, staging the disease requires a liver biopsy. Current treatment relies on weight loss and exercise, although various insulin-sensitizing agents, antioxidants and medications appear promising. The aim of this review is to highlight the current information regarding epidemiology, diagnosis, and management of NAFLD as well as new information about pathogenesis, diagnosis and management of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Gastrointestinal Surgery for Severe Obesity
Panel, C. D. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-12-956 · Cited by 2,163
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C., & Behling, C. (2006) · Pediatrics · doi:10.1542/peds.2006-1212 · Cited by 1,481
The prevalence and etiology of elevated aminotransferase levels in the United States
Clark, J. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00265-x · Cited by 1,360
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
El-serag, H. B., Tran, T., & Everhart, J. E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.10.065 · Cited by 1,230
Mofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
Castéra, L., Foucher, J., Bernard, P.-H., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., & de Lédinghen, V. (2010) · Hepatology · doi:10.1002/hep.23425 · Cited by 1,159
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955
(1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1855 · Cited by 936
Nonalcoholic fatty liver disease
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33573 · Cited by 901
Role of Kupffer cells in host defense and liver disease
Bilzer, M., Roggel, F., & Gerbes, A. L. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01342.x · Cited by 856
Non‐alcoholic fatty liver disease
ANGULO, P., & LINDOR, K. D. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.17.s1.10.x · Cited by 835
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
The epidemiology of nonalcoholic fatty liver disease in adults.
Clark, J. M. (2006) · PubMed · doi:10.1097/01.mcg.0000168638.84840.ff · Cited by 762
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
Davila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El-Serag, H. B. (2005) · Gut · doi:10.1136/gut.2004.052167 · Cited by 704
Metformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
Sleisenger and Fordtran's gastrointestinal and liver disease
Feldman, E. B. M., Friedman, L. S., & Brandt, L. J. (2015) · Elsevier eBooks · Cited by 636
Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., & Gao, B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.055 · Cited by 610
Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot study
Lavine, J. E. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)05040-x · Cited by 531
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Cytokines and Nash: A Pilot Study of the Effects of Lifestyle Modification and Vitamin E
Kugelmas, M., Hill, D. B., Vivian, B., Marsano, L., & McClain, C. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50316 · Cited by 504
NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.
(1991) · PubMed · Cited by 496
Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
Luyckx, F., Desaive, C., Thiry, A., Dewé, W., Scheen, A., Gielen, J., & Lefèbvre, P. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800571 · Cited by 489
Fernandez, F. G., Ritter, J., Goodwin, J. W., Linehan, D. C., Hawkins, W. G., & Strasberg, S. M. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.01.024 · Cited by 465
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Pessayre, D., & Fromenty, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.004 · Cited by 441
Bugianesi, E., Manzini, P., D'Antico, S., Vanni, E., Longo, F., Leone, N., Massarenti, P., Piga, A., Marchesini, G., & Rizzetto, M. (2004) · Hepatology · doi:10.1002/hep.20023 · Cited by 440
Abdelmalek, M. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02691-0 · Cited by 439
Sanyal, A. J., Mofrad, P. S., Contos, M. J., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Clore, J., & Mills, A. S. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00457-4 · Cited by 437
Fatty Liver: Imaging Patterns and Pitfalls
Hamer, O. W., Aguirre, D. A., Casola, G., Lavine, J. E., Woenckhaus, M., & Sirlin, C. B. (2006) · RadioGraphics · doi:10.1148/rg.266065004 · Cited by 433
Liver Markers and Development of the Metabolic Syndrome
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., & Haffner, S. M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3140 · Cited by 419
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
Fan, J.-G., Zhu, J., Li, X.-J., Chen, L., Li, L., Dai, F., Li, F., & Chen, S.-Y. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.042 · Cited by 404
Contos, M. J., Cales, W., Sterling, R. K., Luketic, V. A., Shiffman, M. L., Mills, S. A., Fisher, R. A., Ham, J., & Sanyal, A. J. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23011 · Cited by 400
Amarapurkar, D. N., Hashimoto, E., Lesmana, L. A., Sollano, J. D., Chen, P., Goh, K., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05042.x · Cited by 395
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Argo, C. K., & Caldwell, S. H. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.005 · Cited by 389
Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., Kempf, J., Zinman, B., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2623 · Cited by 385
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., & Perrillo, R. P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02025.x · Cited by 369
Bataller, R., Sancho-bru, P., Ginès, P., Lora, J. M., Al-garawi, A., Solé, M., Colmenero, J., Nicolás, J. M., Jiménez, W., Weich, N., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00695-4 · Cited by 352
Ryan, C. K., Johnson, L. A., Germin, B. I., & Marcos, A. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.36740 · Cited by 326
Thomas, E. L., Hamilton, G., Patel, N., O’Dwyer, R., Doré, C. J., Goldin, R. D., Bell, J. D., & Taylor-Robinson, S. D. (2005) · Gut · doi:10.1136/gut.2003.036566 · Cited by 317
Update on Nonalcoholic Fatty Liver Disease
McCullough, A. J. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200203000-00013 · Cited by 315
A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis
Basaranoglu, M., Acbay, O., & Sonsuz, A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80243-8 · Cited by 305
Pathophysiology of Nonalcoholic Steatohepatitis
Başaranoğlu, M. (2009) · Cited by 293
Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis
Rensen, S. S., Slaats, Y., Nijhuis, J., Jans, A., Bieghs, V., Driessen, A., Malle, E., Greve, J. W., & Buurman, W. A. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080999 · Cited by 290
Fatty acid—induced inflammation and insulin resistance in skeletal muscle and liver
Boden, G. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0031-x · Cited by 276
Church, T. S., Kuk, J. L., Ross, R., Priest, E. L., Biltoff, E., & Blair, S. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.019 · Cited by 268
Nonalcoholic Fatty Liver Disease: A Clinical Review
Sass, D. A., Chang, P., & Chopra, K. B. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-1267-z · Cited by 267
Neutrophil Activation in Morbid Obesity, Chronic Activation of Acute Inflammation
Nijhuis, J., Rensen, S. S., Slaats, Y., van Dielen, F. M. H., Buurman, W. A., & Greve, J. W. M. (2009) · Obesity · doi:10.1038/oby.2009.113 · Cited by 262
Chronic liver injury during obstructive sleep apnea†
Tanné, F., Gagnadoux, F., Chazouillères, O., Fleury, B., Wendum, D., Lasnier, E., Lebeau, B., Poupon, R., & Serfaty, L. (2005) · Hepatology · doi:10.1002/hep.20725 · Cited by 238
Patton, H. M., Sirlin, C., Behling, C., Middleton, M., Schwimmer, J. B., & Lavine, J. E. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000239995.58388.56 · Cited by 237
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
FARRELL, G. C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02989.x · Cited by 235
A Pilot Trial of Pentoxifylline in Nonalcoholic Steatohepatitis
Adams, L. A., Zein, C. O., Angulo, P., & Lindor, K. D. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40064.x · Cited by 234
Body fat distribution, relative weight, and liver enzyme levels: A population-based study
Stranges, S., Dorn, J. M., Muti, P., Freudenheim, J. L., Farinaro, E., Russell, M., Nochajski, T. H., & Trevisan, M. (2004) · Hepatology · doi:10.1002/hep.20149 · Cited by 233
Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo‐controlled trial†
Abdelmalek, M. F., Sanderson, S. O., Angulo, P., Soldevila‐Pico, C., Liu, C., Peter, J., Keach, J., Cave, M., Chen, T., McClain, C. J., et al. (2009) · Hepatology · doi:10.1002/hep.23239 · Cited by 225
Albano, E., Mottaran, E., Vidali, M., Reale, E., Saksena, S., Occhino, G., Burt, A. D., & Day, C. P. (2005) · Gut · doi:10.1136/gut.2004.057968 · Cited by 219
Role of Radiologic Modalities in the Management of Non-alcoholic Steatohepatitis
Charatcharoenwitthaya, P., & Lindor, K. D. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.014 · Cited by 218
Pathophysiology of nonalcoholic steatohepatitis.
McCullough, A. J. (2006) · PubMed · doi:10.1097/01.mcg.0000168645.86658.22 · Cited by 215
Adams, L. A., Lindor, K. D., & Angulo, P. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30444.x · Cited by 207
Nonalcoholic Steatohepatitis in Children: A Multicenter Clinicopathological Study†
Carter-Kent, C., Yerian, L. M., Brunt, E. M., Angulo, P., Kohli, R., Ling, S. C., Xanthakos, S. A., Whitington, P. F., Charatcharoenwitthaya, P., Yap, J., et al. (2009) · Hepatology · doi:10.1002/hep.23133 · Cited by 201
Beymer, C. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.11.1240 · Cited by 200
Satapathy, S. K., Garg, S., Chauhan, R., Sakhuja, P., Malhotra, V., Sharma, B. C., & Sarin, S. K. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40220.x · Cited by 198
Burke, A., & Lucey, M. R. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00432.x · Cited by 191
Immune and inflammatory pathways in NASH
Ganz, M., & Szabo, G. (2013) · Hepatology International · doi:10.1007/s12072-013-9468-6 · Cited by 184
Liangpunsakul, S., & Chalasani, N. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200503000-00001 · Cited by 170
Zakim and Boyer's Hepatology: A Textbook of Liver Disease
BOYER, T. D., Manns, M. P., Sanyal, A. J., & Zakim, D. (2016) · Cited by 168
Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock?
Chitturi, S., Farrell, G. C., & George, J. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2003.03252.x · Cited by 166
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
Serfaty, L., & Lemoine, M. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74597-x · Cited by 166
Clinical approaches to non-alcoholic fatty liver disease
Schwenger, K. J. P., & Allard, J. P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1712 · Cited by 156
Significant correlations between severe fatty liver and risk factors for metabolic syndrome
Hsiao, P., Kuo, K., Shin, S., Yang, Y., Lin, W., Yang, J., Chiu, C., Chuang, W., Tsai, T., & Yu, M. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04698.x · Cited by 155
Imaging of hepatic steatosis and fatty sparing
Karçaaltıncaba, M., & Akhan, O. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.11.005 · Cited by 136
Cheung, O., Kapoor, A., Puri, P., Sistrun, S. N., Luketic, V. A., Sargeant, C., Contos, M. J., Shiffman, M. L., Stravitz, R. T., Sterling, R. K., et al. (2007) · Hepatology · doi:10.1002/hep.21803 · Cited by 136
Liver Pathology in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass Surgery
Gholam, P. M., Kotler, D. P., & Flancbaum, L. (2002) · Obesity Surgery · doi:10.1381/096089202321144577 · Cited by 132
Update on non-alcoholic fatty liver disease in children
Papandreou, D., Rousso, I., & Mavromichalis, I. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.02.002 · Cited by 131
Prevalence and Significance of Autoantibodies in Patients With Non-Alcoholic Steatohepatitis
Cotler, S. J., Kanji, K., Keshavarzian, A., Jensen, D. M., & Jakate, S. M. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000139072.38580.a0 · Cited by 125
Le, T. H., Caldwell, S. H., Redick, J. A., Sheppard, B. L., Davis, C. A., Arseneau, K. O., Iezzoni, J. C., Hespenheide, E. E., Al‐Osaimi, A. M. S., & Peterson, T. C. (2004) · Hepatology · doi:10.1002/hep.20202 · Cited by 125
Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
Gariani, K., Philippé, J., & Jornayvaz, F. R. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.11.002 · Cited by 121
Body Fat Distribution, Liver Enzymes, and Risk of Hypertension
Stranges, S., Trevisan, M., Dorn, J. M., Dmochowski, J., & Donahue, R. P. (2005) · Hypertension · doi:10.1161/01.hyp.0000185688.81320.4d · Cited by 120
Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00395-0 · Cited by 107
Evaluation and management of non-alcoholic steatohepatitis
Ramesh, S., & Sanyal, A. J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.022 · Cited by 105
Epidemiology of alcoholic liver disease.
Lelbach, W. K. (1976) · PubMed · Cited by 104
Rinella, M. E., McCarthy, R., Thakrar, K. H., Finn, J. P., Rao, S. M., Koffron, A. J., Abecassis, M. M., & Blei, A. T. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50153 · Cited by 101
Nonalcoholic Fatty Liver Disease
Lall, C. G., Aisen, A. M., Bansal, N., & Sandrasegaran, K. (2008) · American Journal of Roentgenology · doi:10.2214/ajr.07.2052 · Cited by 97
CT and MRI of diffuse liver disease
Rofsky, N. M., & Fleishaker, H. (1995) · Seminars in Ultrasound CT and MRI · doi:10.1016/0887-2171(95)90012-8 · Cited by 94
The obesity epidemic and nonalcoholic fatty liver disease in children
Dunn, W., & Schwimmer, J. B. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0011-1 · Cited by 91
Use of ursodeoxycholic acid in patients with liver disease
Angulo, P. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0036-9 · Cited by 89
Insulin sensitizers for the treatment of non-alcoholic fatty liver disease
Öztürk, Z. A., & Kadayıfçı, A. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.199 · Cited by 85
Crespo, J., Fernández-Gil, P. L., Hernández‐Guerra, M., Cayón, A., Mayorga, M. M., Domínguez‐Díez, A., Fernández-Escalante, J. C., & Pons‐Romero, F. (2001) · Obesity Surgery · doi:10.1381/096089201321336548 · Cited by 84
Moretto, M., Kupski, C., Mottin, C. C., Repetto, G., Toneto, M. G., Rizzolli, J., Berleze, D., Brito, C. L. D. S., Casagrande, D. S., & de Paris, F. G. C. (2003) · Obesity Surgery · doi:10.1381/096089203322190853 · Cited by 82
Schwimmer, J. B. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-985075 · Cited by 72
Cortez‐Pinto, H., Baptista, A., Camilo, M., & de Moura, M. C. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1026152415917 · Cited by 68
Non-alcoholic Steatohepatitis in Children
Roberts, E. A. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.008 · Cited by 66
NISKANEN, L. K., Uusitupa, M. I. J., Sarlund, H., Siitonen, O., Paljärvi, L., & Laakso, M. (1996) · PubMed · Cited by 65
Effect of Taurine on the Fatty Liver of Children with Simple Obesity
Obinata, K., Maruyama, T., Hayashi, M., Watanabe, T., & Nittono, H. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0182-8_67 · Cited by 63
Nonalcoholic Fatty Liver Disease as a Comorbidity of Childhood Obesity
Barshop, N. J., Francis, C. S., Schwimmer, J. B., & Lavine, J. E. (2009) · Pediatric Health · doi:10.2217/phe.09.21 · Cited by 61
Fatty infiltration of the liver
Pilleul, F., Chave, G., Dumortier, J., Scoazec, J., & Valette, P. (2005) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(05)82179-7 · Cited by 56
Sonsuz, A., Başaranoğlu, M., & Özbay, G. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00838-8 · Cited by 54
Csák, T., Dolganiuc, A., Kodys, K., Nath, B., Petrášek, J., Bala, S., Lippai, D., & Szabó, G. (2011) · Hepatology · doi:10.1002/hep.24301 · Cited by 45
Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
Hsu, C., & Kao, J. (2012) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2012.07.002 · Cited by 38
MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging
Elías, J., Altun, E., Zacks, S., Armao, D. M., Woosley, J. T., & Semelka, R. C. (2009) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2009.02.002 · Cited by 35
Luyckx, F., Scheen, A. J., Desaive, C., Thiry, A., & Lefèbvre, P. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6171-4 · Cited by 27
Nonalcoholic Fatty Liver Disease
Puri, P., & Sanyal, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00053-x · Cited by 17
Öztürk, Y., & Soylu, Ö. B. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i1.33 · Cited by 16
Nonalcoholic Fatty Liver Disease
Reid, A. E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00085-8 · Cited by 6
Mazhar, S. M., Patton, H. M., Scuderi, R. T., Yokoo, T., Faria, S. C., & Sirlin, C. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5449-8.00065-2 · Cited by 4
Cited by
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990
Farzanegi, P., Dana, A., Ebrahimpoor, Z., Asadi, M., & Azarbayjani, M. A. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2019.1571114 · Cited by 379
Le, M. H., Devaki, P., Ha, N. B., Jun, D. W., Te, H. S., Cheung, R. C., & Nguyen, M. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173499 · Cited by 287
Ji, Y., Gao, Y., Chen, H., Yin, Y., & Zhang, W. (2019) · Nutrients · doi:10.3390/nu11092062 · Cited by 288
Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205037 · Cited by 184
Metadata
- Authors
- El-Kader, S. M. A.
- Venue
- World Journal of Hepatology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2015
- Volume
- 7
- Issue
- 6
- Pages
- 846
- ISSN
- 1948-5182 (ISSN-L)
- OpenAlex
- W2038773198
- Cited by
- 381
- References
- 124
- FWCI
- 23.16
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.